Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma
Condition(s):Metastatic Urothelial CarcinomaLast Updated:June 9, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Urothelial CarcinomaLast Updated:June 9, 2023Recruiting
Condition(s):Metastatic Urothelial CarcinomaLast Updated:February 11, 2021Unknown status
Condition(s):Locally Advanced or Metastatic Urothelial CarcinomaLast Updated:September 29, 2020Not yet recruiting
Condition(s):Locally Advanced or Metastatic Urothelial Carcinoma (UC)Last Updated:January 13, 2020Approved for marketing
Condition(s):Metastatic Urothelial CancerLast Updated:March 4, 2020Completed
Condition(s):Metastatic Urothelial Carcinoma (UC)Last Updated:November 16, 2018Terminated
Condition(s):Metastatic Urothelial CarcinomaLast Updated:October 13, 2022Recruiting
Condition(s):Urothelial CarcinomaLast Updated:January 31, 2024Active, not recruiting
Condition(s):Metastatic Urothelial CarcinomaLast Updated:November 30, 2022Completed
Condition(s):Solid Tumors; Metastatic Urothelial Carcinoma & Renal Pelvis & UreterLast Updated:December 24, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.